ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 75 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 6.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $19,000 | -51.3% | 30,100 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $39,000 | -4.9% | 30,100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $41,000 | +41.4% | 30,100 | +49.8% | 0.00% | 0.0% |
| Q1 2018 | $29,000 | -14.7% | 20,100 | +33.1% | 0.00% | 0.0% |
| Q4 2017 | $34,000 | -33.3% | 15,100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $51,000 | -5.6% | 15,100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $54,000 | +5.9% | 15,100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $51,000 | -26.1% | 15,100 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $69,000 | +7.8% | 15,100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $64,000 | – | 15,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,641,025 | $7,549,000 | 1.29% |
| Squarepoint Ops LLC | 10,200 | $47,000 | 0.02% |
| DELTEC ASSET MANAGEMENT LLC | 15,000 | $69,000 | 0.02% |
| FIRST NEW YORK SECURITIES LLC /NY | 5,700 | $26,220,000 | 0.01% |
| WEDBUSH SECURITIES INC | 11,033 | $51,000 | 0.01% |
| Allen Investment Management, LLC | 15,524 | $71,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 14,512 | $67,000 | 0.01% |
| A.R.T. Advisors, LLC | 19,216 | $88,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 134,102 | $617,000 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,105 | $79,000 | 0.00% |